Current Clinical Trials

A clinical trial is a research study that is done to find out if medical treatments can improve people’s health. A medical treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers.  They are also called “participants.”  Clinical Trials FAQs.

Find a Clinical Trial

Therapeutic Area Condition Description  
Bleeding Disorders
Hemophilia A An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A. Learn More
   Hemophilia B A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B Learn  More
   Hemophilia A & B A Study to Investigate the Pharmacokinetics, Efficacy, and Safety of rVIIa-FP (CSL 689) in Subjects With Hemophilia (A or B) and Inhibitors Learn More
  Congenital Fibrinogen Deficiency An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency  Completed
  Von Willebrand Disease Study of Voncento® in Subjects With Von Willebrand Disease Completed
  Warfarin Reversal An Observational Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA® Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding Learn More
Cardiovascular Acute Coronary Syndrome Study to investigate CSL112 in Subjects With Acute Coronary Syndrome Learn More
  Coronary Heart Disease

Assessing the pharmacokinetics, safety, and tolerability of CSL112 in healthy Japanese and Caucasian adults

Learn More
Immunoglobulins  Chronic Inflammatory Demyelinating Polyneuropathy Extension Study of Maintenance Treatment with Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed
  Primary Immune Deficiency  Study of Immune Deficiency Patients treated with Subcutaneous Immunoglobulin (IgPro20, Hizentra) on Weekly and Biweekly Schedules Completed
  Primary Immune Deficiency Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) Learn More
Therapeutic Proteins Other Inflammatory or immune system disorders Dose escalation, placebo-controlled phase 1 study to assess the safety and tolerability of CSL324 in healthy adults Learn More
Transplant Antibody-mediated kidney transplant rejection Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients Learn More
How to Enroll into a Study

Find out if enrolling in a clinical trial is right for you.

Learn More
Product Pipeline

Delve into our portfolio of new products, improved products and manufacturing expertise.

Learn More
Clinical Trials

Learn what a trial is and why it is important.

Learn More

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter